BridgeMD
New treatment option for Neuro ICU
Official title Comparison of Ultrasound Cerebral Perfusion Imaging With Routine Perfusion CT
ClinicalTrials.gov ID: NCT07324421
What this study is testing
- What it's testing
- The primary goal of neurocritical care is to prevent secondary brain injury, which worsens neurological outcomes. Because clinical monitoring is often insufficient due to the patient's condition and medical treatments, multimodal monitoring using biophysical, electrophysiological, and imaging data is essential.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient ≥ 18 years old
- Patient Informed Consent, or from his/her relative if the patient is not conscious and able to consent
- Admission to ICU or CCU with indication to perform at least one CTP
- Affiliated with or benefiting from a social security scheme
- The subject's current clinical status, as assessed by medical history, physical examination, and/or relevant tests, indicates that they do not...
You likely can't join if
- Guardianship, curatorship or any deprivation of liberty by judicial or administrative decision
- Pregnant or breast-feeding women
- Known contra-indication or hypersensitivity to SonoVue® (to sulfur hexafluoride microbubbles or to one of its excipients such as polyethylene glycol...
- Right-to-left shunts
- Patients who have undergone craniectomy in the temporal region
- Patients with open wounds or recent scars in the temporal region
See the full eligibility criteria
- Patient ≥ 18 years old
- Patient Informed Consent, or from his/her relative if the patient is not conscious and able to consent
- Admission to ICU or CCU with indication to perform at least one CTP
- Affiliated with or benefiting from a social security scheme
- The subject's current clinical status, as assessed by medical history, physical examination, and/or relevant tests, indicates that they do not require immediate medical treatment or emergency care at the time of...
- Guardianship, curatorship or any deprivation of liberty by judicial or administrative decision
- Pregnant or breast-feeding women
- Known contra-indication or hypersensitivity to SonoVue® (to sulfur hexafluoride microbubbles or to one of its excipients such as polyethylene glycol (PEG))
- Right-to-left shunts
- Patients who have undergone craniectomy in the temporal region
- Patients with open wounds or recent scars in the temporal region
- Unstable hemodynamic or respiratory state contraindicating transportation to CTP scanner
The study team makes the final eligibility decision.
Where it's taking place
- Montpellier, Herault, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montpellier, Herault, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.